MedPath

Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy

Not Applicable
Completed
Conditions
Written Exposure Therapy
Imaginal Exposure Therapy
Interventions
Behavioral: Written Exposure Therapy
Behavioral: Imaginal Exposure Therapy
Registration Number
NCT04000217
Lead Sponsor
Palo Alto Veterans Institute for Research
Brief Summary

The purpose of the study is to compare the efficacy of two different versions of a brief online exposure therapy program for PTSD: written versus verbal trauma narrative recounting in reducing PTSD symptom severity. Both treatments will be delivered through an interactive online program with coaching from a trained peer support specialist. Treatment will be a variable length, such that 4 to 8 sessions will be delivered, depending on each participants' rate of PTSD symptom recovery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Able to read/write English
  • Internet connection allowing stable access to the Vets Prevail website
  • A clinically significant PCL-5 score of 31 or above.
Exclusion Criteria
  • A score on the suicidality item of the PHQ-9 of 3 or higher.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Written Exposure TherapyWritten Exposure TherapyWritten exposure therapy (Sloan et al., 2012) is a brief evidence-based treatment for PTSD (US Dept. of VA \& DoD, 2017), wherein patients are asked to write about their trauma memories for 30 minutes, with therapist instruction and feedback before and after each writing exercise.
Imaginal Exposure TherapyImaginal Exposure TherapyImaginal exposure therapy will involve verbal recounting of trauma memories for 30 minutes with therapist instruction and feedback before and after each recounting exercise.
Primary Outcome Measures
NameTimeMethod
Post Traumatic Stress Disorder CheckList for Diagnostic and Statistical Manual - 5 (PCL-5; Weathers, et al., 2013)Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).

Self report measure of PTSD symptoms. A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items. Higher scores indicate greater PTSD severity.

Secondary Outcome Measures
NameTimeMethod
Brief version of the difficulties in emotion regulation scale (DERS-16; Bjureberg et al,. 2016)Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).

A 16-item self report measure of difficulties in emotion regulation. Total scores on the DERS-16 can range from 16 to 80, with higher scores reflecting greater levels of emotion dysregulation.

Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001).Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).

Self report measure of depression symptoms. It is the 9-item measure that yields a total score of 0-27, with higher scores indicating greater depressive symptom severity.

Work and Social Adjustment Scale (WSAS; Mundt et al., 2002)Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).

A 5-item self-report measure of work and social functioning and impact of symptoms. Total scores range from 0-40 with higher scores indicating greater impairment.

Trial Locations

Locations (1)

Prevail Health Inc.

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath